CRVS - CIK 0001626971
Corvus Pharmaceuticals, Inc. trades as CRVS and has a market capitalization of $945.18 M, making it the #2651 largest US-listed company by market value. This page tracks Corvus Pharmaceuticals, Inc. through 570 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-07 |
| Employee stock plan | S-8 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-04-27 |
The largest companies sharing Corvus Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $945.18 M as of 2026-06-10, ranking #2651 among US-listed companies.
In its latest fiscal year Corvus Pharmaceuticals, Inc. reported a net loss of $15.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.